Ayana Kon
Minato, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives.
Journal: Japanese journal of clinical oncology
Published: June 19, 2026
Splicing Factor Mutations in Clonal Hematopoiesis and Progression to Myeloid Neoplasms.
Journal: Cancer science
Published: March 02, 2026
Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.
Journal: Blood
Published: October 16, 2025
Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.
Journal: Blood
Published: October 16, 2025
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia.
Journal: Nature
Published: February 28, 2025
SETBP1 is dispensable for normal and malignant hematopoiesis.
Journal: Leukemia
Published: November 21, 2022
Germ line DDX41 mutations define a unique subtype of myeloid neoplasms.
Journal: Blood
Published: August 23, 2022
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia.
Journal: Blood cancer discovery
Published: October 18, 2021
Clonal evolution of myeloid malignancies
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: November 09, 2020
Clonal evolution of myelodysplastic syndromes
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: May 08, 2020
Last Updated: 09/26/2026